www.natera.com
Open in
urlscan Pro
2600:9000:214f:7600:a:c669:ef80:93a1
Public Scan
Submitted URL: http://natera.com/
Effective URL: https://www.natera.com/
Submission: On October 06 via manual from US — Scanned from DE
Effective URL: https://www.natera.com/
Submission: On October 06 via manual from US — Scanned from DE
Form analysis 2 forms found in the DOM
GET https://www.natera.com/
<form role="search" method="get" id="search-mobile-form" action="https://www.natera.com/" cr-attached="true">
<div class="searchbox__controls">
<label class="screen-reader-text" for="search-mobile">Search for:</label>
<input type="text" value="" placeholder="Search..." name="s" id="search-mobile">
<div class="searchbox__buttons">
<button aria-label="Reset" class="searchbox__clear-icon hidden" type="reset"></button>
<button aria-label="Submit" class="searchbox__submit" type="submit"></button>
</div>
</div>
</form>GET https://www.natera.com/
<form role="search" method="get" id="searchform" action="https://www.natera.com/" cr-attached="true">
<div class="searchbox__controls">
<label class="screen-reader-text" for="search">Search for:</label>
<input type="text" value="" placeholder="Search..." name="s" id="search">
<div class="searchbox__buttons">
<button aria-label="Reset" class="searchbox__clear-icon hidden" type="reset"></button>
<button aria-label="Submit" class="searchbox__submit" type="submit"></button>
</div>
</div>
</form>Text Content
Cookie Policy
We use cookies on this site to enhance your user experience. By clicking any
link on this page you are giving your consent for us to set cookies. No, give me
more info
I AgreeDismiss Cookie Preferences
Skip navigation
Signatera now covered by Medicare in muscle invasive bladder cancer.
Learn More
Pay Bill Portals
* Our Tests
* * Oncology
* * TESTS
* * Signatera – Residual Disease Test (MRD)
* Altera – Tumor Genomic profile
* Empower – Hereditary Cancer Test
* * FOR PATIENTS
* * Signatera Patient Information
* Signatera for Colorectal Cancer
* Signatera for Bladder Cancer
* Signatera for Immunotherapy
* Signatera for Lung Cancer
* Signatera for Skin Cancers
* Signatera for Gynecologic Cancers
* * FOR CLINICIANS
* * Signatera for Colorectal Cancer
* Signatera for Bladder Cancer
* Signatera for Immunotherapy Monitoring
* Signatera for Lung Cancer
* Signatera for Skin Cancers
* Signatera for Gynecologic Cancers
* Signatera Research Pipeline
* Oncology Portal
* Organ Health
* * TESTS
* * Prospera Kidney – Transplant Assessment
* Prospera Heart – Transplant Assessment
* Prospera Lung – Transplant Assessment
* Renasight – Kidney Gene Panel
* * FOR PATIENTS
* * Prospera for Kidney Patients
* Prospera for Heart Patients
* Prospera for Lung Patients
* Renasight Patient Information
* * FOR CLINICIANS
* * Prospera for Kidney Clinician
* Renasight Clinician Information
* Renasight Gene Conditions List
* Organ Health Portal
* Women’s Health
* * TESTS
* * Horizon – Advanced Carrier Screening
* Panorama – Noninvasive Prenatal Testing (NIPT)
* Empower – Hereditary Cancer Test
* Vistara – Single-Gene NIPT
* Anora – Miscarriage Test
* Spectrum – Preimplantation Genetics
* Vasistera – Limited Noninvasive Prenatal Testing (NIPT)
* * FOR PATIENTS
* * Pricing and Billing Information
* Women’s Health Portal
* * FOR CLINICIANS
* * NateraConnect Provider Portal
* Horizon Conditions List
* NEVA for Empower – Natera’s Educational Virtual Assistant
* Our Services
* * Oncology
* * SERVICES
* * NateraCore Services
* Pharma Partnership
* * FOR PATIENTS
* * Schedule Session with Patient Coordinator
* Pricing and Billing Information
* Contact Us
* * FOR CLINICIANS
* * Schedule Session With Client Services
* Oncology Portal
* Order a Test Kit
* Contact Us
* Organ Health
* * SERVICES
* * NateraCore Services
* ProReach
* * FOR PATIENTS
* * Schedule a Genetic Information Session
* Contact Us
* * FOR CLINCIANS
* * Organ Health Portal
* Contact Us
* Women’s Health
* * SERVICES
* * NateraCore Services
* Constellation
* * FOR PATIENTS
* * Schedule a Genetic Information Session
* Pricing and Billing Information
* Women’s Health Portal
* Contact Us
* * FOR CLINICIANS
* * Order Tests and Track Status on NateraConnect
* View Patient Results on NateraConnect
* Contact Us
* Patient Resources
* * Oncology
* * LEARN
* * Blog
* Brochures
* Manuals
* Studies
* Videos
* View All Patient Resources
* * EXISTING PATIENTS
* * Schedule Blood Draw (Existing Patients)
* Schedule Session with Patient Coordinator
* Pricing and Billing Information
* * CONNECT
* * Contact Us
* Organ Health
* * LEARN
* * Brochures
* Manuals
* Podcasts
* Reports
* Studies
* Videos
* View All Patient Resources
* * EXISTING PATIENTS
* * Schedule Blood Draw (Existing Patients)
* Schedule a Genetic Information Session
* * CONNECT
* * Contact Us
* Women’s Health
* * LEARN
* * Blogs
* Brochures
* Manuals
* Videos
* Webinars
* View All Patient Resources
* * EXISTING PATIENTS
* * Schedule a Genetic Information Session
* Schedule Blood Draw (Existing Patients)
* Pricing and Billing Information
* Women’s Health Portal
* * CONNECT
* * Contact Us
* Clinical Resources
* * Oncology
* * CLINICAL RESOURCES
* * Blog
* Manuals
* Peer-reviewed Publications
* Posters
* Reports
* Videos
* Whitepapers
* View All Clinician Resources
* * RESEARCH STUDIES
* * Signatera Research Pipeline
* BESPOKE CRC
* BESPOKE IO
* * CONNECT
* * Oncology Portal
* Contact Us
* Organ Health
* * CLINICAL RESOURCES
* * Brochures
* Manuals
* Peer-reviewed Publications
* Podcasts
* Reports
* Studies
* Videos
* Webinars
* View All Clinician Resources
* * RESEARCH STUDIES
* * ProActive Study
* PEDAL Study
* Trifecta Study
* MOTR Study
* * CONNECT
* * Organ Health Portal
* Contact Us
* Women’s Health
* * CLINICAL RESOURCES
* * Blog
* Brochures
* Manuals
* Peer-reviewed Publications
* Webinars
* Videos
* Natera Academy Provider Education Hub
* View All Clinician Resources
* * RESEARCH STUDIES
* * CONNECT
* * Contact Us
* Company
* * About Us
* Our People
* Our Technology
* News
* Events
* Careers
* Investor Relations
* Social Responsibility
* Contact Us
* Search for:
* Pay Bill
Portals
* Click to show search bar
* Search for:
PROTECT HEALTH AND INFORM EARLIER, MORE TARGETED INTERVENTIONS
Natera’s cell-free DNA tests help inform more personalized health
care decisions.
TEST
Measure fetal, tumor, or donor DNA at the molecular level with a noninvasive
test.
KNOW
Identify risk of disease, detect recurrence, and understand treatment responses.
DECIDE
Make more-informed health decisions for individualized care.
DEDICATED TO ONCOLOGY, WOMEN’S HEALTH, AND ORGAN HEALTH
ONCOLOGY TESTS
Characterize tumors, anticipate risk, and evaluate treatment response earlier
than traditional tools. Hear Jeff’s story.
Learn More
WOMEN’S HEALTH TESTS
Identify risk of severe genetic conditions to help families prepare and inform
early intervention that can improve outcomes. Hear Corrine’s story.
Learn More
ORGAN HEALTH TESTS
Detect organ injury early and inform treatment strategy to improve transplant
health. Hear Gigi’s story.
Learn More
INNOVATING WITH INTEGRITY
INNOVATING WITH INTEGRITY
Natera advances molecular diagnostics with integrity and scientific rigor, and
supports integration of information provided by our tests into health care
decision making. Our tests are clinically validated in over 100 peer-reviewed
publications with over 1.3 million patients studied.
We participated in the largest prospective studies to date in molecular
diagnostics in oncology (CIRCULATE), women’s health (SMART), and organ health
(Trifecta). We meet or exceed applicable industry and regulatory standards for
all of our tests to deliver high-quality results, and have processed over 5
million tests in our CAP/CLIA‑certified labs.
We have more than 150 medical professionals on staff who provide expert support
to help make our test results clear and easy to understand.
CREATING A WORLD OF POSSIBILITIES
Natera advances molecular diagnostics with integrity and scientific rigor, and
supports integration of information provided by our tests into health care
decision making.
NATERA NEWS
* NATERA ANNOUNCES 2025 ESG GOALS WITH PUBLICATION OF 2021 REPORT
* NATERA ANNOUNCES Q-SUB FILING WITH FDA FOR ITS PANORAMA NIPT
* NEW PUBLICATION VALIDATES PERFORMANCE OF NATERA'S SIGNATERA MRD TEST IN
OVARIAN CANCER
* TRIFECTA STUDY DEMONSTRATES PROSPERA KIDNEY DD-CFDNA TEST OUTPERFORMS DSA IN
PREDICTING ANTIBODY MEDIATED REJECTION
* NATERA ANNOUNCES 2025 ESG GOALS WITH PUBLICATION OF 2021 REPORT
* NATERA ANNOUNCES Q-SUB FILING WITH FDA FOR ITS PANORAMA NIPT
* NEW PUBLICATION VALIDATES PERFORMANCE OF NATERA'S SIGNATERA MRD TEST IN
OVARIAN CANCER
* TRIFECTA STUDY DEMONSTRATES PROSPERA KIDNEY DD-CFDNA TEST OUTPERFORMS DSA IN
PREDICTING ANTIBODY MEDIATED REJECTION
*
*
*
*
LOOKING FOR MORE INFORMATION?
Let us help you find your way
I am a selectclinicianpatientresearcherselect looking for tests and resources
for selectoncologyorgan healthwomen's healthselect Show me
--------------------------------------------------------------------------------
* Our Tests
* Oncology
* Organ Health
* Women’s Health
* Our Services
* Oncology Core
* Organ Health Core
* Women’s Health Core
* Patient Resources
* Resource Library
* Pricing & Billing
* Pay Bill
* Patient Portals
* Clinical Resources
* Resource Library
* Provider Portals
* Company
* About Us
* Our People
* Our Technology
* News
* Events
* Careers
* Investor Relations
* Social Responsibility
* Contact
* Contact Us
* Schedule Blood Draw (Existing Patients)
* Schedule a Genetic Information Session
*
*
*
*
* Natera Licenses
* IT Security Compliance
* Natera Notice of Data Collection for California Residents
* Privacy Practices
* Privacy Policy
* Terms of Use
* Sitemap
Designed by Elegant Themes | Powered by WordPress
The tests described have been developed and their performance characteristics
determined by the CLIA-certified laboratory performing the test. The tests have
not been cleared or approved by the US Food and Drug Administration (FDA).
Although FDA is exercising enforcement discretion of premarket review and other
regulations for laboratory-developed tests in the US, certification of the
laboratory is required under CLIA to ensure the quality and validity of the
tests. CAP accredited, ISO 13485 certified, and CLIA certified. © 2022 Natera,
Inc. All Rights Reserved.